F-D-C Reports, Inc. Launches PharmAsiaNews.com
New online service covering RX drugs, biologics and devices
Rockville, Md. - January 14, 2008 - F-D-C Reports, Inc. announces the launch of PharmAsiaNews.com: a new subscription-based online service covering Rx drugs, biologics and devices in China, India, Japan and other nations in the Pacific Rim.
“By leveraging the editorial excellence of “The Pink Sheet,” the leading information source for U.S. pharmaceutical industry information since 1939 into the Asian markets and combining it with new features enabled by Web 2.0 technology, we believe PharmAsiaNews.com will become an important information service to multinational pharmaceutical companies who are making increasingly larger bets in the region” said Gerry Stoia, V.P. of Elsevier Health Science Division’s Pharma Solutions unit and President of F-D-C Reports, Inc.
“Increasingly over the past several years, customers have requested reliable, independent and accurate ‘Pink Sheet like’ coverage of business and regulatory developments in the APAC region. F-D-C Reports, Inc. has answered the call for information on developments in China, India, Japan and other countries in the region via our PharmAsiaNews.com service,” Stoia added.
The result is a publication that provides readers with the broadest spectrum of news sources, including: original on-the-ground reporting from news bureaus across Asia; guest columns; exclusive interviews; news summaries; English translation summaries of Chinese- and Japanese-language news; and aggregated content from around the globe.
“What makes PharmAsiaNews.com unique is our commitment to original local market coverage and insights developed by local staff who are resident in the market. This is not a service that provides solely rewritten press releases and translated local language stories. By leveraging Elsevier’s global footprint, we’ve brought local talent aboard to provide our customers with the ‘boots on the ground’ coverage our customers have requested,” said Joe Hecker, Editor-in-Chief at Elsevier’s F-D-C Reports, Inc.
Subscribers to PharmAsiaNews.com get online access to around-the-clock coverage of the rapidly expanding Asia marketplace, including China, India, Japan and other nations in the Pacific Rim; twice-weekly email updates; full archive access; breaking news alerts; and other online resources.
# # #
About F-D-C Reports
F-D-C Reports, Inc. provides up-to-date information about the worldwide health care industry via its publications including The Pink Sheet®, The Gray Sheet®, The Rose Sheet®, The Tan Sheet®, and Pharmaceutical Approvals Monthly. The publications are read extensively by pharmaceutical and healthcare executives, policy-makers, and analysts seeking to understand the developments affecting the U.S. regulation and marketing of healthcare products and services. F-D-C Reports, Inc. has one of the largest, most experienced, and most respected editorial teams reporting on the latest regulatory, legislative, and business news affecting the U.S. drug, biotechnology, medical device, nonprescription drug, nutritionals, and cosmetics industries. F-D-C Reports, Inc. is part of Elsevier.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
F-D-C Reports, Inc.
+1 240 221 4535